Fundraising Fox

XII Medical

Union City, US · Founded 2017 · Delaware corporation · 7 known investors

xiimedical.com ↗

XII Medical develops neuromodulation therapies for treating obstructive sleep apnea, focusing on simplifying treatment options and improving patient outcomes.

Deep TechDigital HealthHealthtechMedical Devices

Founders & leadership

GS
Garrett SchwabChief Executive Officer
SKShane Kreidel
Shane KreidelinChief Financial OfficerPartner at Ajax Health
ZE
Zachary EisenNamed on SEC filing

Board

DRDuke Rohlen
Duke RohleninBoard directorCEO and Managing Partner at Ajax Health
JF
JD FriedlandBoard director
SB
Saoussen Ben HalimaBoard directorPrincipal at Omega Funds
TNTony Natale
Tony NataleinBoard directorManaging Partner at APERTURE Venture Partners
AKAftab Kherani
Aftab KheraniinBoard MemberManaging Partner at Ajax Health
RG
Raman GowriBoard director
DGDaniel Gottlieb
Daniel GottliebinBoard of DirectorsDirector at Broadview Ventures

Investors · 7

APERTURE Venture PartnersBoston · $1M – $5M
Broadview VenturesBoston
CincyTechCincinnati · $500K – $750K
Intuitive VenturesSunnyvale
JobsOhio VenturesColumbus
Ajax HealthreportedMenlo Parkvia Duke Rohlen · board
Omega Fundsreported · 2 sourcesBostonvia Saoussen Ben Halima · board

Reported raises · per SEC filings

Form D private placements

$45.1M disclosed across 3 rounds · 2020–2024

▶$22.5MraisedAug 2024 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Garrett SchwabExecutive Officer, Director
  • Duke RohlenDirector
  • JD FriedlandDirector
  • Saoussen Ben HalimaDirector
  • Shane KreidelExecutive Officer
  • Raman GowriDirector
  • Tony NataleDirector
  • Daniel GottliebDirector
Offering amount
$45M
Amount sold
$22.5M
First sale
Aug 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.1MraisedApr 2022 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Garrett SchwabExecutive Officer, Director
  • Aftab KheraniDirector
  • Zachary EisenDirector
  • Tony NataleDirector
  • Duke RohlenDirector
  • JD FriedlandDirector
  • Shane KreidelExecutive Officer
  • Raman GowriDirector
  • Daniel GottliebDirector
Offering amount
$15.1M
Amount sold
$15.1M
Minimum investment
$4M
Proceeds to insiders
$300K
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.5MraisedApr 2022 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Zachary EisenDirector
  • Tony NataleDirector
  • Garrett SchwabExecutive Officer, Director
  • Duke RohlenDirector
  • Daniel GottliebDirector
  • Shane KreidelExecutive Officer
  • Raman GowriDirector
  • Aftab KheraniDirector
  • JD FriedlandDirector
Offering amount
$15M
Amount sold
$7.5M
First sale
Apr 2022
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Massdevice3 shared keywordsMassDevice is a news and media outlet covering the medical device industry, publishing articles, special reports, and white papers on medtech companies, products, and regulatory topics such as FDA 510(k) submissions. It serves medical device professionals with industry news and analysis.

Companies competing with XII Medical for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

XII Medical, a Cleveland Clinic spinoff, raises $45 million in Series B financing - Crain's Cleveland Businesscrainscleveland.com · Sep 2024Top digital health funding: Oncology Ventures, XII Medical - Modern Healthcaremodernhealthcare.com · Aug 2024XII Medical Raises $45 Million in Series B - Sanctuary Software Studio, Inc.sancsoft.com · Aug 2024XII Medical raises $45M to support sleep apnea neuromodmassdevice.com · Aug 2024XII MEDICAL RAISES $45 MILLION IN SERIES B FINANCING TO ADVANCE BEST-IN-CLASS NEUROMODULATION THERAPY FOR OBSTRUCTIVE SLEEP APNEAprnewswire.com · Aug 2024XII MEDICAL RAISES $45 MILLION IN SERIES B FINANCING TO ADVANCE BEST-IN-CLASS NEUROMODULATION THERAPY FOR OBSTRUCTIVE SLEEP APNEA - Broadview Venturesbroadviewventures.org · Aug 2024

Frequently asked questions

What does XII Medical do?
XII Medical develops neuromodulation therapies for treating obstructive sleep apnea, focusing on simplifying treatment options and improving patient outcomes.
Who are XII Medical's investors?
XII Medical's investors include APERTURE Venture Partners, Broadview Ventures, CincyTech, Intuitive Ventures, JobsOhio Ventures, Ajax Health, Omega Funds.
How much funding has XII Medical raised?
XII Medical has disclosed $45.1M raised across 3 rounds.
Where is XII Medical headquartered?
XII Medical is headquartered in Union City, US.